Sentry Investment Management’s West Pharmaceutical WST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-144
Closed -$40K 492
2025
Q4
$40K Hold
144
0.03% 416
2025
Q3
$39K Sell
144
-70
-33% -$17K 0.03% 427
2025
Q2
$47K Hold
214
0.03% 410
2025
Q1
$43K Sell
214
-64
-23% -$17.6K 0.03% 387
2024
Q4
$91K Sell
278
-45
-14% -$14.2K 0.04% 317
2024
Q3
$97K Hold
323
0.04% 342
2024
Q2
$106K Sell
323
-66
-17% -$23.3K 0.05% 309
2024
Q1
$154K Hold
389
0.06% 278
2023
Q4
$137K Sell
389
-42
-10% -$14.9K 0.06% 286
2023
Q3
$162K Sell
431
-76
-15% -$29.4K 0.08% 257
2023
Q2
$194K Buy
507
+23
+5% +$8.22K 0.07% 273
2023
Q1
$168K Buy
+484
New +$141K 0.07% 281
2022
Q4
Sell
-494
Closed -$122K 540
2022
Q3
$122K Hold
494
0.06% 321
2022
Q2
$149K Sell
494
-96
-16% -$31.2K 0.07% 283
2022
Q1
$242K Sell
590
-99
-14% -$38.8K 0.08% 257
2021
Q4
$323K Hold
689
0.08% 240
2021
Q3
$293K Sell
689
-101
-13% -$42.6K 0.09% 241
2021
Q2
$284K Hold
790
0.07% 266
2021
Q1
$223K Sell
790
-19,059
-96% -$5.45M 0.06% 296
2020
Q4
$5.62M Sell
19,849
-1,277
-6% -$358K 0.28% 90
2020
Q3
$5.81M Sell
21,126
-2,051
-9% -$543K 0.32% 76
2020
Q2
$5.26M Buy
+23,177
New +$4.55M 0.32% 77

Other funds holding WST

Sentry Investment Management's WST Position: Q1 2026 in Review

Sentry Investment Management sold out of West Pharmaceutical (WST) in Q1 2026, closing a stake of 144 shares — an estimated $40K sold.

Sentry Investment Management first reported a position in WST in Q2 2020 and held it in 22 quarters. The position peaked at $5.81M in Q3 2020. 755 funds tracked by Wall St. Rank hold WST as of Q1 2026.

  • Sentry Investment Management reported no remaining West Pharmaceutical position as of Q1 2026 after selling out during the quarter.
  • Sentry Investment Management sold 144 West Pharmaceutical shares in Q1 2026, an estimated $40K.
  • Sentry Investment Management first reported a position in West Pharmaceutical in Q2 2020 and held it in 22 quarters.
  • Sentry Investment Management's West Pharmaceutical position peaked at $5.81M in Q3 2020.
  • 755 funds tracked by Wall St. Rank held West Pharmaceutical as of Q1 2026.

Based on Sentry Investment Management's 13F filing for Q1 2026, filed 8 May 2026.